Menu
Search
Home > Courses > Update from IAS-2019 Mexico City: Focus on HIV Treatment and Prevention

Update from IAS-2019 Mexico City: Focus on HIV Treatment and Prevention

Update from IAS-2019 Mexico City: Focus on HIV Treatment and Prevention
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Approval Date: 8/20/2019
Published Date: 10/21/2019
Presenter
  • Roy M. Gulick, MD, MPH
    Rochelle Belfer Professor in Medicine, Chief, Division of Infectious Diseases, Weill Cornell Medicine
    Weill Medical College of Cornell University, New York, NY
Presenter Bio
Roy Gulick, MD, MPH

Roy M. Gulick, MD, MPH research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the ACTG and the HIV Prevention Trials Network (HPTN), sponsored by the NIH.

Continuing Education Credit (The CE accreditation for this course has expired - this section is only for your information)

This CME activity was approved for AMA PRA Category 1 Credit on August 20, 2019 and will terminate August 19, 2022.


The target audience is all physicians, NPs and PAs involved or interested in HIV education.


This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.


The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Roy Gulick, MD, MPH (Presenter) had no relevant financial relationships to disclose. Dr. Gulick submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules